Podcast: On Psychedelics: Promising Benefits and Significant Risks
, we speak with Richard A. Friedman, M.D. about the latest news exploring the intersection of psychedelics and psychiatry. Dr. Friedman highlights the effects psychedelic drugs have on the brain’s neuroplasticity, misconceptions about mind altering drugs, and the surprising findings of research on the drugs’ mental health benefits and risks.
Please note that the use of psychedelics is not FDA approved and is only to be used by in medical research settings under strict safety protocols.
referenced in this episode.
Featured Speaker: Richard A. Friedman, M.D. is a professor of clinical psychiatry and director of the Psychopharmacology Clinic at ÎåÔÂÌìÊÓƵ. His clinical and research focus is on anxiety, mood disorders, psychopharmacology, and refractory depression.
On the Mind is the official podcast from the ÎåÔÂÌìÊÓƵ Department of Psychiatry. Each episode, hosted by Daniel Knoepflmacher, M.D., Vice Chair of Education and Training Director of the general psychiatry residency program, focuses on discussions with renowned professors, leading researchers, and expert practitioners from ÎåÔÂÌìÊÓƵ as they discuss the brain, mental health, and important questions on the mind.